Graff Jeremy R. — SEC insider filings

SEC reporting owner CIK 1975028. 15 insider filings on record with FilingPulse; latest filed 2026-10-09.

Transaction summary — filings shown

Covers all 15 filings on record, filed 2023-05-03 to 2026-10-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
IN8BIO, INC. (INAB)Director91 leg · 2,500 sh · $2,375—11
Allarity Therapeutics, Inc. (ALLR)See Remarks6——13

Insider filings — Graff Jeremy R.

FiledFormIssuerReported transactionsSource
2026-10-094Allarity Therapeutics, Inc. (ALLR)Option exercise (M): 48,147 · Tax withholding (F): 17,814 @ $1.18 · Option exercise (M): 39,494 · Tax withholding (F): 14,613 @ $0.97 · Option exercise (M): 48,147 (derivative) @ $0 · Option exercise (M): 39,494 (derivative) @ $0EDGAR
2026-05-124IN8BIO, INC. (INAB)Grant/award (A): 22,000 (derivative) @ $0EDGAR
2026-04-304/AAllarity Therapeutics, Inc. (ALLR)Grant/award (A): 133,333 @ $0EDGAR
2026-01-164Allarity Therapeutics, Inc. (ALLR)Grant/award (A): 133,333 @ $0EDGAR
2025-10-024Allarity Therapeutics, Inc. (ALLR)Option exercise (M): 39,494 · Tax withholding (F): 14,613 @ $1.58 · Option exercise (M): 39,494 (derivative) @ $0EDGAR
2025-05-124IN8BIO, INC. (INAB)Grant/award (A): 63,150 (derivative) @ $0EDGAR
2025-05-074IN8BIO, INC. (INAB)Disposition to issuer (D): 2,049 (derivative) · Grant/award (A): 2,049 (derivative)EDGAR
2025-01-244Allarity Therapeutics, Inc. (ALLR)Grant/award (A): 144,441 @ $0EDGAR
2024-12-234IN8BIO, INC. (INAB)Grant/award (A): 47,697 (derivative) @ $0EDGAR
2024-10-014Allarity Therapeutics, Inc. (ALLR)Grant/award (A): 118,483 @ $2.11EDGAR
2024-06-144IN8BIO, INC. (INAB)Grant/award (A): 33,650 (derivative) @ $0EDGAR
2023-12-154IN8BIO, INC. (INAB)Grant/award (A): 2,049 · Grant/award (A): 2,049 (derivative) · Grant/award (A): 2,049 (derivative)EDGAR
2023-09-154IN8BIO, INC. (INAB)Purchase (P): 2,500 @ $0.95EDGAR
2023-06-164IN8BIO, INC. (INAB)Grant/award (A): 85,000 (derivative) @ $0EDGAR
2023-05-034IN8BIO, INC. (INAB)Grant/award (A): 27,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2022-05-23 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1975028 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs